comparemela.com

Page 7 - மருந்து அடையாளம் எண் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advisory - Unauthorized injectables and other health products from Galena Pharm Inc pharmacy may pose serious health risks

Share: Summary Products: Unauthorized health products from Galena Pharm Inc. pharmacy, including vitamins, minerals, amino acids, naturopathic cancer therapy and other therapies administered by injection or infusion in health settings, such as clinics, and non-injectable products such as capsules and suppositories that patients may have in their homes. Issue: These products are unauthorized and may pose serious health risks. For example, one injectable product called reduced glutathione was found to contain high levels of endotoxin, a harmful substance produced by bacteria. What to do: Health care practitioners should stop administering and selling these products, and patients should stop using them after confirming with their health care practitioner. Patients should consult their health care practitioner if they have questions about whether they have received treatment using a Galena Pharm Inc. product and have questions or concerns about their health.

Tetra Bio-Pharma Files New Drug Submission for REDUVO in Canada

Tetra Bio-Pharma Files New Drug Submission for REDUVO in Canada Tetra meets another key milestone before the end of the year OTTAWA, ON / ACCESSWIRE / December 30, 2020 / Tetra Bio-Pharma Inc. ( Tetra or the Company ) (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development announced today that the New Drug Submission (NDS) for the Dronabinol Soft Gel capsules, has been filed with Health Canada. If successful, it will provide Tetra with its first Drug Identification Number (DIN) for a THC-based prescription drug. The new drug name, REDUVO, is pending approval by Health Canada. REDUVO will allow Tetra to establish a revenue stream based on a synthetic cannabinoid drug for major markets in Chemotherapy-induced Nausea and Vomiting (CINV). The addressable market is estimated to be $80M CDN by 2022

Heypur Added to List of Recalled Hand-Sanitizers Due to Unacceptable Medicinal Ingredient

Heypur Added to List of Recalled Hand-Sanitizers Due to ‘Unacceptable Medicinal Ingredient’ Health Canada continues to update the list of recalled hand sanitizers that pose potential health risks for consumers. HeyPur (NPN 80099351), produced by Heyseller Inc., was added to the list of hand sanitizers being recalled from the market on Dec. 11, because it contains an “unacceptable medicinal ingredient, 1-propanol.” “Frequent use of hand sanitizer containing 1-propanol may cause eye, nose and throat irritation, as well as dry cracking skin, drowsiness and headache,” the agency said in a release. The COVID-19 pandemic has increased the demand for hand sanitizer, and Health Canada responded by temporarily permitting the use of “technical-grade ethanol in alcohol-based hand sanitizers.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.